CMap Candidate Details
                      
                      Structure:
                         
                      
                  
                  | CMap ID: | C05699 | 
| Pert ID: | BRD-K72951360 | 
| Compound Name: | valrubicin | 
| Targets: | TOP2A | 
| MoA: | DNA inhibitor; topoisomerase inhibitor | 
| SMILES: | CCCCC(=O)OCC(=O)[C@@]1(O)C[C@H](O[C@H]2C[C@H](NC(=O)C(F)(F)F)[C@H](O)[C@H](C)O2)c2c(O)c3C(=O)c4c(OC)cccc4C(=O)c3c(O)c2C1 | 
| InchiKey: | |
| Compound Aliases: | 
| Score ID | Pert ID | Cell Line | Pert Dose | Pert Time | Raw Score (GSE126848) | Normalized Score (GSE126848) | fdr_q_nlog10 (GSE126848) | Raw Score (GSE135251) | Normalized Score (GSE135251) | fdr_q_nlog10 (GSE135251) | 
|---|---|---|---|---|---|---|---|---|---|---|
| 126639 | BRD-K72951360 | A375 | 1.11 uM | 24 h | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 
| 126660 | BRD-K72951360 | A549 | 10 uM | 24 h | -0.24 | -1.02 | 0.17 | 0.0 | 0.0 | 0.0 | 
| 126679 | BRD-K72951360 | HA1E | 0.37 uM | 24 h | 0.0 | 0.0 | 0.0 | -0.3 | -1.0 | 0.53 | 
| 126700 | BRD-K72951360 | HEK293 | 3.33 uM | 24 h | 0.28 | 1.16 | 0.36 | -0.33 | -1.09 | 0.84 | 
| 126728 | BRD-K72951360 | HELA | 1.11 uM | 24 h | 0.3 | 1.24 | 0.53 | -0.36 | -1.23 | 1.25 | 
| 126790 | BRD-K72951360 | JURKAT | 3.33 uM | 24 h | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 
| 126817 | BRD-K72951360 | MCF10A | 3.33 uM | 24 h | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 
| 126859 | BRD-K72951360 | MCF??7.00 | 3.33 uM | 24 h | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 
| 126903 | BRD-K72951360 | MDAMB231 | 0.37 uM | 24 h | 0.0 | 0.0 | 0.0 | 0.27 | 0.95 | 0.31 | 
| 126922 | BRD-K72951360 | PC3 | 3.33 uM | 24 h | 0.17 | 0.72 | 0.0 | 0.25 | 0.89 | 0.2 | 
| 126973 | BRD-K72951360 | THP1 | 10 uM | 24 h | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 
| 127004 | BRD-K72951360 | YAPC | 1.11 uM | 24 h | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 
| 134836 | BRD-K72951360 | HT29 | 2.22 uM | 24 h | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 
| 134887 | BRD-K72951360 | HUVEC | 2.22 uM | 24 h | 0.0 | 0.0 | 0.0 | -0.34 | -1.16 | 1.11 | 
 
    